Hypertension in rheumatic diseases: prevalence, awareness, treatment, and control rates according to current hypertension guidelines

被引:11
|
作者
Anyfanti, Panagiota [1 ]
Gkaliagkousi, Eugenia [1 ]
Triantafyllou, Areti [1 ]
Koletsos, Nikolaos [1 ]
Gavriilaki, Eleni [1 ]
Galanopoulou, Vasiliki [2 ]
Aslanidis, Spyros [3 ]
Douma, Stella [1 ]
机构
[1] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Internal Med 3, Thessaloniki, Greece
[2] Papageorgiou Hosp, Dept Rheumatol, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Hippokrat Hosp, Propedeut Dept Internal Med 2, Dept Rheumatol, Thessaloniki, Greece
关键词
CARDIOVASCULAR RISK-FACTORS; QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; ARTHRITIS; MANAGEMENT; IMPACT;
D O I
10.1038/s41371-020-0348-y
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a major modifiable risk factor for cardiovascular disease. Autoimmune rheumatic diseases confer increased cardiovascular risk, which is at least partially mediated by traditional cardiovascular risk factors. We examined the prevalence, awareness, treatment, and control rates of hypertension in a large cohort of patients with rheumatic diseases. Consecutive patients attending the Rheumatology omicron utpatient Clinics were studied. Hypertension was defined by both the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines and the 2017 American College of Cardiology/American Heart Association (ACC/AHA). In a total of 622 individuals, hypertension prevalence reached 54.5% according to the 2018 ESH/ESC guideline, with the highest rates observed in patients with osteoarthritis (69.6%), rheumatoid arthritis (60.9%), and psoriatic arthritis (57.8%). Among hypertensive individuals, 21.7% were unaware of high blood pressure levels, while 67.2% were treated. Only 48.6% of treated hypertensives reached the 2018 ESC/ESH treatment goals. Applying the 2017 ACC/AHA criteria would result in a substantial increase of hypertension prevalence (72.4%) for both genders and especially among younger individuals, accompanied by a dramatic drop in control rates among treated patients (16.7%). In conclusion, comorbid hypertension was highly prevalent in a large cohort of patients with rheumatic diseases according to ESH/ESC and especially, ACC/AHA guidelines. However, it remains underdiagnosed and undertreated in a significant portion, while control rates are far from optimal. Our findings highlight the importance of systematic screening and more aggressive treatment of hypertension among patients with rheumatic diseases.
引用
收藏
页码:419 / 427
页数:9
相关论文
共 50 条
  • [1] Hypertension in rheumatic diseases: prevalence, awareness, treatment, and control rates according to current hypertension guidelines
    Panagiota Anyfanti
    Eugenia Gkaliagkousi
    Areti Triantafyllou
    Nikolaos Koletsos
    Eleni Gavriilaki
    Vasiliki Galanopoulou
    Spyros Aslanidis
    Stella Douma
    [J]. Journal of Human Hypertension, 2021, 35 : 419 - 427
  • [2] PREVALENCE, AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN A LARGE COHORT OF PATIENTS WITH RHEUMATIC DISEASES
    Anyfanti, P.
    Triantafyllou, A.
    Gkaliagkousi, E.
    Koletsos, N.
    Dolgyras, P.
    Galanopoulou, V.
    Aslanidis, S.
    Douma, S.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 : E167 - E168
  • [3] Ethnicity Disparities in the Prevalence, Awareness, Treatment, and Control Rates of Hypertension in China
    Yang, Yanan
    He, Kunlin
    Zhang, Yuewen
    Wu, Xiuming
    Chen, Weizhong
    Gu, Dongqing
    Zeng, Ziqian
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2023, 2023
  • [4] Prevalence, Awareness, Treatment And Control Of Hypertension In Awareness Campaigns
    Bareta Sironi, Brenda
    Komagome, Bruno Jun
    Bueno Junior, Carlos Roberto
    Seixas da Silva, Carol Esli
    Carnaval Chitolina, Felipe
    Barbosa de Oliveira, Joanna
    Luisa, de Lamare dos Santos Paula
    Martins Prizao, Vitoria
    Passos Okawa, Rogerio Toshiro
    [J]. HYPERTENSION, 2020, 76
  • [5] Knowledge and awareness of current guidelines in prevention and treatment of hypertension
    Fotino, D.
    Makeen, A.
    Pogribna, L.
    Bazzano, L. A.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 404 - 404
  • [6] Changes in prevalence, awareness, treatment, and control of hypertension
    Domarkiene, S
    Tamosiunas, A
    Reklaitiene, R
    Sidlauskiene, D
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2004, 14 (04): : 87 - 87
  • [7] Prevalence, Awareness, Treatment, and Control of Hypertension in Lebanon
    Matar, Dany
    Frangieh, Antonio H.
    Abouassi, Samah
    Bteich, Fernand
    Saleh, Aline
    Salame, Elie
    Kassab, Roland
    Azar, Rabih R.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2015, 17 (05): : 381 - 388
  • [8] Prevalence, awareness, treatment, and control of hypertension in China
    Gu, DF
    Reynolds, K
    Wu, XG
    Chen, J
    Duan, XF
    Muntner, P
    Huang, GY
    Reynolds, RF
    Su, SY
    Whelton, PK
    He, J
    [J]. HYPERTENSION, 2002, 40 (06) : 920 - 927
  • [9] Hypertension in Delhi: prevalence, awareness, treatment and control
    Chaturvedi, S.
    Pant, M.
    Neelam
    Yadav, G.
    [J]. TROPICAL DOCTOR, 2007, 37 (03) : 142 - 145
  • [10] Prevalence, Awareness, Treatment, and Control of Hypertension in Korea
    Si-Hyuck Kang
    Sun-Hwa Kim
    Jun Hwan Cho
    Chang-Hwan Yoon
    Seung-Sik Hwang
    Hae-Young Lee
    Tae-Jin Youn
    In-Ho Chae
    Cheol-Ho Kim
    [J]. Scientific Reports, 9